BioCentury
ARTICLE | Company News

Gilead, Roche infectious news

August 18, 2014 7:00 AM UTC

Gilead disclosed in an SEC filing last week that an arbitration panel ruled that Roche failed to establish its claims to Gilead’s HCV drug Sovaldi sofosbuvir. Roche initiated arbitration against Gile...